Successfully treated invasive pulmonary aspergillosis in a patient with diabetic ketoacidosis

• Authors: Ryo Kumagai , Gen Ohara , Shinya Sato , Kunihiko Miyazaki , Katsunori Kagohashi , Koichi Kurishima , Hiroaki Satoh
• Languages of publication: EN

Abstracts

EN

We report herein a case of diabetic ketoacidosis associated with invasive aspergillosis that was successfully treated with liposomal amphotericin-B (L-AMB). Early intervention after confirming the diagnosis of invasive pulmonary aspergillosis is very important, and initiating early treatment with L-AMB can lead to a full recovery.

Keywords

EN

Invasive pulmonary aspergillosis; Diabetic ketoacidosis; Liposomal amphotericin-B

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2013
• Volume: 8
• Issue: 5
• Pages: 685-688

Dates

published

1 - 10 - 2013

online

18 - 9 - 2013

Contributors

author

Ryo Kumagai

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

author

Gen Ohara

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

author

Shinya Sato

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

author

Kunihiko Miyazaki

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

author

Katsunori Kagohashi

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

author

Koichi Kurishima

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

author

Hiroaki Satoh

• Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki, 310-0015, Japan

References

• [1] Andriola VT. Serodiagnosis of aspergillosis. In: Bennet JE, Hay RJ, Peterson PK, eds. New Strategies in Fungal Disease. New York: Churchill Livingstone, 1991; 245–256
• [2] Degregorio MW, Lee WMF, Linekar CA, Jacobbs RA, Reis CA. Fungal infections in patients with acute leukaemia. Am J Med 1982; 73: 543–548 http://dx.doi.org/10.1016/0002-9343(82)90334-5[Crossref]
• [3] Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990; 12: 1147–1201 http://dx.doi.org/10.1093/clinids/12.6.1147[Crossref]
• [4] Aisner J, Schnipff SC, Wiernik PH. Treatment of invasive aspergillosis: relation of early diagnosis and treatment response. Ann Intern Med 1977; 86: 539–543 http://dx.doi.org/10.7326/0003-4819-86-5-539[Crossref]
• [5] Burnie JP, Matthews RC. Recent laboratory observations in the diagnosis of systemic fungal infection: Candida and Aspergillus. In: Holmberg K, Meyer RD, eds. Diagnosis and Therapy of Systemic Infections. New York: Raven Press, 1989; 101–l13
• [6] Ronald MG. Invasive aspergillosis. Rev Infect Dis 1983; 5: 1061–1077 http://dx.doi.org/10.1093/clinids/5.6.1061[Crossref]
• [7] Karam GH, Griffin FM. Invasive pulmonary aspergillosis in non-immunocompromised, non-neutropenic hosts. Rev Infect Dis 1986; 8: 357–363 http://dx.doi.org/10.1093/clinids/8.3.357[Crossref]
• [8] Horn CL, Wood NC, Hughes JA. Invasive pulmonary aspergillosis following post influenza pneumonia. Br J Dis Chest 1983; 77: 407–410 http://dx.doi.org/10.1016/0007-0971(83)90078-5[Crossref]
• [9] Rinaldi MG. Invasive aspergillus. Rev Znfect Dis 1983; 5: 1061–1077 http://dx.doi.org/10.1093/clinids/5.6.1061[Crossref]
• [10] Grizzanti JN, Knapp A. Diabetic ketoacidosis and invasive aspergillosis. Lung 1981; 159: 43ȁ349 http://dx.doi.org/10.1007/BF02713896[Crossref]
• [11] Janes SM, Barker KF, Mak V, Bell D. Invasive pulmonary aspergillosis in an insulin-dependent diabetic. Respir Med 1998; 92: 972–975 http://dx.doi.org/10.1016/S0954-6111(98)90201-3[Crossref]
• [12] De Rosa FG, Terragni P, Pasero D, et al. Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report. Intensive Care Med 2009; 35: 1641–1643 http://dx.doi.org/10.1007/s00134-009-1546-9[WoS][Crossref]
• [13] Vaschetto R, Kroumova V, Olivieri C, et al. Early diagnosis of invasive pulmonary aspergillosis in a young immunocompetent patient. New Microbiol 2012; 35: 77–82
• [14] D’Silva H, Burtle JF, Cho SY. Disseminated aspergillosis in an apparently immunocompetent host. J Am Med Assoc 1982; 248: 1495–1497 http://dx.doi.org/10.1001/jama.1982.03330120053031[Crossref]
• [15] Schaffuer A, Douglas H, Braude A. Selective protection against candida by mononuclear and against my-Celia by polymorphonuclear phagocytes in resistance to aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982; 69: 617–631 http://dx.doi.org/10.1172/JCI110489[Crossref]
• [16] Polat G, Urpek G, Yilmaz U, et al. Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host. Respirology 2005 10: 393–395 http://dx.doi.org/10.1111/j.1440-1843.2005.00690.x[Crossref]
• [17] Brook O, Guralnik L, Hardak E, et al. Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients. Hematol Oncol 2009; 27: 102–106 http://dx.doi.org/10.1002/hon.879[WoS][Crossref]
• [18] Singer C, Armstronge D, Rosen PB, Walzer PB, Yu B. Diffuse pulmonary infiltrates in immunosuppressed patients-prospective study of 80 patients. Am J Med 1979; 66: 110–120 http://dx.doi.org/10.1016/0002-9343(79)90490-X[Crossref]
• [19] Ramsey PG, Rubin RH, Tolkoff-Rubin NE, Cusini AB, Russell PS, Greene R. The renal transplant patient with fever and infiltrates-aetiology, clinical manifestations and managements. Medicine 1980; 59: 206–222 http://dx.doi.org/10.1097/00005792-198005000-00003[Crossref]
• [20] Greenmon RL, Goodall PT, King D. Lung biopsy in immunocompromised hosts. Am J Med 1975; 59: 488–496 http://dx.doi.org/10.1016/0002-9343(75)90256-9[Crossref]
• [21] Gallien S, Fournier S, Porcher R, et al. Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases. Infection 2008; 36: 533–538 http://dx.doi.org/10.1007/s15010-008-7375-x[Crossref][WoS]
• [22] Heykants J, van Peer A, van de Velde V, van Rooy P, Meuldermans W, Lavrijsen K. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1990; 32(Suppl 1): 67–87
• [23] Denning DW, Lee JY, Hostetler JS et al. NIAID mycoses group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97: 135–144 http://dx.doi.org/10.1016/0002-9343(94)90023-X[Crossref]
• [24] Watkins PJ, Soler NG, Fitzgerald MG, Malins JM. Diabetic ketoacidosis during the influenza epidemic. Br Med J 1970; 4(5727): 89–91 http://dx.doi.org/10.1136/bmj.4.5727.89[Crossref]
• [25] Bouter KP, Diepersloot RJ, van Romunde LK, et al. Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976–1979 in The Netherlands. Diabetes Res Clin Pract 1991; 12: 61–68 http://dx.doi.org/10.1016/0168-8227(91)90131-V[Crossref]

Identifiers

DOI

10.2478/s11536-013-0188-z